Smith Group Asset Management, LLC Corcept Therapeutics Inc Transaction History
Smith Group Asset Management, LLC
- $1.36 Trillion
- Q4 2024
A detailed history of Smith Group Asset Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Smith Group Asset Management, LLC holds 15,408 shares of CORT stock, worth $1.05 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,408
Previous 15,256
1.0%
Holding current value
$1.05 Million
Previous $706 Million
9.97%
% of portfolio
0.06%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding CORT
# of Institutions
361Shares Held
86.6MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$1.13 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$681 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$551 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$443 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$259 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.29B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...